The cardiovascular system is composed of the heart and blood vessels. Most cardiovascular research focuses on understanding how disease develops within the cardiovascular system and how it may be prevented or treated. Cardiovascular disease (CVD) includes the conditions: coronary artery disease, stroke, heart failure, angina, myocardial infarction, cardiomyopathy, hypertensive heart disease, rheumatic heart disease, arrhythmia, congenital heart disease, aortic aneurysms, and venous thromboembolism.
The prevalence of CVD is increasing globally, with the specific causative mechanisms depending on the type of CVD. For example, the main cause of coronary artery disease and stroke is atherosclerosis, which is caused by: high blood pressure, high blood cholesterol, diabetes mellitus, obesity, or smoking. High blood pressure is estimated to account for ten to fifteen percent of all CVD related deaths, with smoking accounting for an estimated ten percent, and obesity an estimated five percent. It is speculated that up to ninety percent of all cases of CVD may be preventable through tackling risk factors, including: diet, exercise, smoking, and alcohol consumption. Treatment of risk factors, such as high blood pressure, elevated blood lipids, and diabetes, shows considerable benefit for preventing / limiting the progression of CVD.
We offer a comprehensive portfolio of antibodies, proteins, and assays for cardiovascular research that exhibit high specificity, activity, performance, and reproducibility in a range of techniques, including: Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), and ELISA. These tools are commonly used to study the cardiovascular system, angiogenesis, atherosclerosis, and the development of disease.